These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1321654)

  • 1. Effects of granisetron and haloperidol, alone and in combination, on psychometric performance and the EEG.
    Leigh TJ; Link CG; Fell GL
    Br J Clin Pharmacol; 1992 Jul; 34(1):65-70. PubMed ID: 1321654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of granisetron and lorazepam, alone and in combination, on psychometric performance.
    Leigh TJ; Link CG; Fell GL
    Br J Clin Pharmacol; 1991 Mar; 31(3):333-6. PubMed ID: 1647193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of granisetron and lorazepam, alone and in combination, on the EEG of human volunteers.
    Link CG; Leigh TJ; Fell GL
    Br J Clin Pharmacol; 1991 Jan; 31(1):93-7. PubMed ID: 1849732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects produced by acute and chronic treatment with granisetron alone or in combination with haloperidol on midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):127-33. PubMed ID: 1321681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.
    Upward JW; Arnold BD; Link C; Pierce DM; Allen A; Tasker TC
    Eur J Cancer; 1990; 26 Suppl 1():S12-5. PubMed ID: 2169778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of BRL 46470A, a novel 5-HT3 receptor antagonist, and lorazepam on psychometric performance and the EEG.
    Link CG; Leigh TJ; Dennison JK
    Br J Clin Pharmacol; 1993 Apr; 35(4):395-9. PubMed ID: 8485019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):489-95. PubMed ID: 6139346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system effects of haloperidol on THC in healthy male volunteers.
    Liem-Moolenaar M; te Beek ET; de Kam ML; Franson KL; Kahn RS; Hijman R; Touw D; van Gerven JM
    J Psychopharmacol; 2010 Nov; 24(11):1697-708. PubMed ID: 20142302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human responses to inhaled capsaicin are not inhibited by granisetron.
    Choudry NB; McEwan JR; Lavender EA; Williams AJ; Fuller RW
    Br J Clin Pharmacol; 1991 Mar; 31(3):337-9. PubMed ID: 1647194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers.
    McClelland GR; Cooper SM; Pilgrim AJ
    Br J Clin Pharmacol; 1990 Dec; 30(6):795-803. PubMed ID: 2288826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance task.
    Chugh Y; Saha N; Sankaranarayanan A; Sharma PL
    Eur J Pharmacol; 1991 Oct; 203(1):121-3. PubMed ID: 1665786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remoxipride versus haloperidol in healthy volunteers: psychometric performance and subjective tolerance profiles.
    Rammsayer T; Gallhofer B
    Int Clin Psychopharmacol; 1995 Mar; 10(1):31-7. PubMed ID: 7622802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychomotor effects of paroxetine alone and in combination with haloperidol, amylobarbitone, oxazepam, or alcohol.
    Cooper SM; Jackson D; Loudon JM; McClelland GR; Raptopoulos P
    Acta Psychiatr Scand Suppl; 1989; 350():53-5. PubMed ID: 2530791
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects.
    Saarialho-Kere U
    Br J Clin Pharmacol; 1988 Jul; 26(1):79-87. PubMed ID: 3060191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
    Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX
    Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans.
    Vitiello B; Martin A; Hill J; Mack C; Molchan S; Martinez R; Murphy DL; Sunderland T
    Neuropsychopharmacology; 1997 Jan; 16(1):15-24. PubMed ID: 8981385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of granisetron and placebo for the treatment of acute migraine in the emergency department.
    Rowat BM; Merrill CF; Davis A; South V
    Cephalalgia; 1991 Nov; 11(5):207-13. PubMed ID: 1663423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.
    Liem-Moolenaar M; Gray FA; de Visser SJ; Franson KL; Schoemaker RC; Schmitt JA; Cohen AF; van Gerven JM
    J Psychopharmacol; 2010 Jan; 24(1):73-82. PubMed ID: 18755817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the antiemetic effectiveness of granisetron and alizapride plus dexamethasone in cytostatic therapy].
    Bremer K; Uhlenbusch R
    Dtsch Med Wochenschr; 1991 Nov; 116(48):1817-23. PubMed ID: 1659980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group.
    Chevallier B
    Eur J Cancer; 1990; 26 Suppl 1():S33-6. PubMed ID: 2169784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.